Cannabis Global, Inc. (CBGL)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Cannabis Global Cash from Financing (Quarterly) : 0.00 for Aug. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2025 | 0.00 |
| May 31, 2025 | 0.00 |
| February 28, 2025 | -0.0651M |
| November 30, 2024 | 0.0651M |
| August 31, 2024 | 0.00 |
| May 31, 2024 | 0.00 |
| February 29, 2024 | 0.0651M |
| November 30, 2023 | 0.00 |
| August 31, 2023 | 0.00 |
| May 31, 2023 | 0.0235M |
| February 28, 2023 | -0.0543M |
| November 30, 2022 | 0.0551M |
| August 31, 2022 | 0.0628M |
| May 31, 2022 | -0.156M |
| February 28, 2022 | 0.6699M |
| November 30, 2021 | 0.0595M |
| August 31, 2021 | -0.0872M |
| May 31, 2021 | 0.69M |
| February 28, 2021 | 0.5516M |
| November 30, 2020 | 0.3525M |
| August 31, 2020 | |
| May 31, 2020 | 0.4632M |
| February 29, 2020 | 0.4331M |
| November 30, 2019 | 0.095M |
| August 31, 2019 | 0.2423M |
| Date | Value |
|---|---|
| May 31, 2019 | 0.0131M |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.0154M |
| August 31, 2018 | 0.007M |
| May 31, 2018 | 0.0233M |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.0052M |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.07M |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 0.00 |
Cash From Financing Definition
Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.016M |
| CorMedix, Inc. | -6.894M |
| Eloxx Pharmaceuticals, Inc. | 60.39M |
| Breakthrough Chemistry, Inc. | 0.00 |
| BioStem Technologies, Inc. | -1.146M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.112M |